Komori
Veritas In Silico (130A) · InitiativeAdvanced

Securing and Developing Specialized Personnel

First written in FY2023. 4 of 7 entries say "Advanced", first in FY2025. Latest entry: FY2026-H1.

7entries
3years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2025 – FY2026-H12024: 120242025: 020252026: 62026
Same theme, other companies
Strengthening the recruitment and development of advanced technical and IT specialistsA theme 255 companies write about · 11 as a headwind · 262 as a tailwind

108 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 273 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「In addition to using AI, we are strengthening our research structure with a view to the future, including by hiring additional researchers and upgrading research equipment. As part of these efforts, in April we opened the Kawasaki Research Center by relocating and expanding the facilities and functions previously located at the Shinkawasaki Research Center.」

    In addition to increasing the number of researchers and updating research equipment, the company concretely strengthened its research structure by opening the Kawasaki Research Institute in April 2026 after relocating and expanding the facilities and functions of the Shinkawasaki Research Institute.
  2. FY2025AdvancedAnnual report

    「Regarding our research and development structure, we increased the number of researchers at the Shinkawasaki Research Institute in FY2025 to strengthen our capabilities in preparation for new joint drug-discovery research, including with overseas companies. In addition to expanding and strengthening the platform business, we also advanced efforts to expand and relocate research facilities in preparation for promoting the pipeline business.」

    The company strengthened its personnel and research structure through increased recruitment of researchers, expansion and relocation of research facilities, and internal study sessions in preparation for joint research with overseas companies and the pipeline business.
  3. FY2023First statedAnnual report

    「To significantly develop our business, we need personnel with a high level of expertise in RNA research and extensive drug-discovery research experience, as well as personnel who can contribute to expanding business development. We will work to secure talented personnel by enhancing our website and actively using recruitment agencies. We will also develop personnel who will support our future by creating an environment in which employees can work comfortably and grow through their work.」

    The company plans to recruit specialists in RNA and drug-discovery research and business development, and develop them in an environment where they can work comfortably and grow.
Moved together

"Expansion into ASO, mRNA therapeutics, and ncRNA-targeted therapeutics" moved the same way as this thread, in the same document, in 5 of its 7 moves.

554432★123456
  1. ★This thread
  2. 1Expansion into ASO, mRNA therapeutics, and ncRNA-targeted therapeutics5×
  3. 2First proprietary pipeline targeting ischemic acute kidney failure5×
  4. 3Perfusio-Based Nucleic Acid Pharmaceutical Delivery, Shorter Development Timelines, and Commercialization4×
  5. 4Ongoing Acquisition of New Collaborative Drug Discovery Research Agreements4×
  6. 5Creation of the Second In-House Pipeline in Fiscal 20263×
  7. 6Expansion of the in-house pipeline business targeting nucleic acid drugs and small-molecule drugs2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Veritas In Silico yet. It last moved in the Earnings presentation of 2026-08-05: "Achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.